Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Annales De Chirurgie
|
July 25, 2003
[Spontaneous splenic rupture: report of three new cases and review of the literature]
R Kianmanesh, H I Aguirre, F Enjaume, et al.
Surgery
|
March 1, 1984
Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion
E Delva, J P Barberousse, B Nordlinger, et al.
Journal of Medicinal Chemistry
|
May 7, 1999
Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors
B Vacher, B Bonnaud, P Funes, et al.
Diseases of the Colon and Rectum
|
July 1, 1994
Curative resection for left colonic carcinoma: hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for Surgical Research
F Rouffet, J M Hay, B Vacher, et al.
European Journal of Pharmacology
|
June 16, 2001
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential
W Koek, B Vacher, C Cosi, et al.
British Journal of Pharmacology
|
August 20, 2010
Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias
C Pignier, J-S Rougier, B Vié, et al.
FEBS Letters
|
July 10, 1998
Adhesion-related glycocalyx study: quantitative approach with imaging-spectrum in the energy filtering transmission electron microscope (EFTEM)
M Soler, S Desplat-Jego, B Vacher, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
|
November 1, 2005
Conformational analysis and crystal structure of {[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4yl]methyl}[(5-methylpyridin-2-yl)methyl]amine, fumaric acid salt
J P Ribet, R Pena, J L Maurel, et al.
British Journal of Pharmacology
|
March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia
R Depoortère, L Bardin, A L Auclair, et al.
British Journal of Pharmacology
|
March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms
R Depoortère, A L Auclair, L Bardin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Annales De Chirurgie
|
July 25, 2003
[Spontaneous splenic rupture: report of three new cases and review of the literature]
R Kianmanesh, H I Aguirre, F Enjaume, et al.
Surgery
|
March 1, 1984
Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion
E Delva, J P Barberousse, B Nordlinger, et al.
Journal of Medicinal Chemistry
|
May 7, 1999
Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors
B Vacher, B Bonnaud, P Funes, et al.
Diseases of the Colon and Rectum
|
July 1, 1994
Curative resection for left colonic carcinoma: hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for Surgical Research
F Rouffet, J M Hay, B Vacher, et al.
European Journal of Pharmacology
|
June 16, 2001
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential
W Koek, B Vacher, C Cosi, et al.
British Journal of Pharmacology
|
August 20, 2010
Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias
C Pignier, J-S Rougier, B Vié, et al.
FEBS Letters
|
July 10, 1998
Adhesion-related glycocalyx study: quantitative approach with imaging-spectrum in the energy filtering transmission electron microscope (EFTEM)
M Soler, S Desplat-Jego, B Vacher, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
|
November 1, 2005
Conformational analysis and crystal structure of {[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4yl]methyl}[(5-methylpyridin-2-yl)methyl]amine, fumaric acid salt
J P Ribet, R Pena, J L Maurel, et al.
British Journal of Pharmacology
|
March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia
R Depoortère, L Bardin, A L Auclair, et al.
British Journal of Pharmacology
|
March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms
R Depoortère, A L Auclair, L Bardin, et al.
Page
of 4